XML 26 R5.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total Stockholder's Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Deferred Compensation
Noncontrolling Interests
Total
Beginning Balance at Oct. 31, 2021 $ 642,438 $ 1 $ 1,908,507 $ (1,265,251) $ (819) $ (586) $ 586   $ 642,438
Beginning Balance at (in shares) at Oct. 31, 2021   12,220,600              
Sale of common stock, net of fees 183,552   183,552           183,552
Sale of common stock, net of fees (in shares)   1,279,897              
Common stock issued, non-employee compensation 305   305           $ 305
Common stock issued, non-employee compensation (in shares)   2,562             2,562
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (1,840)   (1,840)           $ (1,840)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   17,998              
Share based compensation 6,792   6,792           6,792
Preferred dividends - Series B (3,200)   (3,200)           (3,200)
Effect of foreign currency translation (933)       (933)       (933)
Adjustment for deferred compensation           (269) 269    
Adjustment for deferred compensation (in shares)   (2,314)              
Reclassification of redeemable non-controlling interest               $ 12,419 12,419
Return of capital to noncontrolling interest               (496) (496)
Distribution to non-controlling interest               (308) (308)
Net Loss (142,722)     (142,722)       (4,510) (147,232)
Ending Balance at Oct. 31, 2022 684,392 $ 1 2,094,116 (1,407,973) (1,752) (855) 855 7,105 691,497
Ending Balance at (in shares) at Oct. 31, 2022   13,518,743              
Sale of common stock, net of fees 97,439 $ 1 97,438           97,439
Sale of common stock, net of fees (in shares)   1,477,361              
Common stock issued, non-employee compensation 225   225           $ 225
Common stock issued, non-employee compensation (in shares)   3,454             3,454
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (829)   (829)           $ (829)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   24,768              
Share based compensation 11,954   11,954           11,954
Preferred dividends - Series B (3,200)   (3,200)           (3,200)
Effect of foreign currency translation 80       80       80
Adjustment for deferred compensation           (223) 223    
Adjustment for deferred compensation (in shares)   (3,454)              
Contributions received for sale of noncontrolling interest               9,052 9,052
Reclassification of redeemable non-controlling interest               3,030 3,030
Distribution to non-controlling interest               (744) (744)
Net Loss (107,568)     (107,568)       (488) (108,056)
Ending Balance at Oct. 31, 2023 682,493 $ 2 2,199,704 (1,515,541) (1,672) (1,078) 1,078 17,955 $ 700,448
Ending Balance at (in shares) at Oct. 31, 2023   15,020,872             15,020,872
Sale of common stock, net of fees 92,555   92,555           $ 92,555
Sale of common stock, net of fees (in shares)   5,302,378              
Common stock issued, non-employee compensation 159   159           $ 159
Common stock issued, non-employee compensation (in shares)   6,651             6,651
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (951)   (951)           $ (951)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   50,358              
Share based compensation 11,764   11,764           11,764
Preferred dividends - Series B (3,200)   (3,200)           (3,200)
Effect of foreign currency translation 111       111       111
Adjustment for deferred compensation           (120) 120    
Adjustment for deferred compensation (in shares)   (4,327)              
Contributions received for sale of noncontrolling interest               25,122 25,122
Distribution to non-controlling interest               (1,621) (1,621)
Net Loss (126,009)     (126,009)       (30,769) (156,778)
Ending Balance at Oct. 31, 2024 $ 656,922 $ 2 $ 2,300,031 $ (1,641,550) $ (1,561) $ (1,198) $ 1,198 $ 10,687 $ 667,609
Ending Balance at (in shares) at Oct. 31, 2024   20,375,932             20,375,932